Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X F Steven Zheng

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Current Issues in Molecular Biology|April 5, 2002
Chemical genomics: a systematic approach in biological research and drug discoveryX F Steven Zheng, Ting-Fung Chan
RNA Biology|October 4, 2024
Role of RNA polymerase III transcription and regulation in ischaemic strokeChi Kwan Tsang, X F Steven Zheng
Reviews on Recent Clinical Trials|September 28, 2010
Recent clinical trials of mTOR-targeted cancer therapiesAruni S Arachchige Don, X F Steven Zheng
Cell Cycle (Georgetown, Tex.)|August 3, 2007
Compacting DNA during the interphase: condensin maintains rDNA integrityChi Kwan Tsang, Yuehua Wei, X F Steven Zheng
Drug Discovery Today|February 22, 2011
Targeting the mTOR kinase domain: the second generation of mTOR inhibitorsYan-Jie Zhang, Yanwen Duan, X F Steven Zheng
Cell Cycle (Georgetown, Tex.)|December 30, 2009
mTOR binds to the promoters of RNA polymerase I- and III-transcribed genesChi Kwan Tsang, Hui Liu, X F Steven Zheng
The EMBO Journal|July 4, 2009
Mechanisms of regulation of RNA polymerase III-dependent transcription by TORC1Yuehua Wei, Chi Kwan Tsang, X F Steven Zheng
Drug Discovery Today|February 9, 2021
Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinomaHong Zhang, Kristen Spencer, Stephen K Burley, et al.
Theranostics|May 13, 2022
mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinomaHong Zhang, Xiaoyang Su, Stephen K Burley, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
Nuclear SOD1 in Growth Control, Oxidative Stress Response, Amyotrophic Lateral Sclerosis, and CancerJoyce Xu, Xiaoyang Su, Stephen K Burley, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Current Issues in Molecular Biology|April 5, 2002
Chemical genomics: a systematic approach in biological research and drug discoveryX F Steven Zheng, Ting-Fung Chan
RNA Biology|October 4, 2024
Role of RNA polymerase III transcription and regulation in ischaemic strokeChi Kwan Tsang, X F Steven Zheng
Reviews on Recent Clinical Trials|September 28, 2010
Recent clinical trials of mTOR-targeted cancer therapiesAruni S Arachchige Don, X F Steven Zheng
Cell Cycle (Georgetown, Tex.)|August 3, 2007
Compacting DNA during the interphase: condensin maintains rDNA integrityChi Kwan Tsang, Yuehua Wei, X F Steven Zheng
Drug Discovery Today|February 22, 2011
Targeting the mTOR kinase domain: the second generation of mTOR inhibitorsYan-Jie Zhang, Yanwen Duan, X F Steven Zheng
Cell Cycle (Georgetown, Tex.)|December 30, 2009
mTOR binds to the promoters of RNA polymerase I- and III-transcribed genesChi Kwan Tsang, Hui Liu, X F Steven Zheng
The EMBO Journal|July 4, 2009
Mechanisms of regulation of RNA polymerase III-dependent transcription by TORC1Yuehua Wei, Chi Kwan Tsang, X F Steven Zheng
Drug Discovery Today|February 9, 2021
Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinomaHong Zhang, Kristen Spencer, Stephen K Burley, et al.
Theranostics|May 13, 2022
mTOR regulates aerobic glycolysis through NEAT1 and nuclear paraspeckle-mediated mechanism in hepatocellular carcinomaHong Zhang, Xiaoyang Su, Stephen K Burley, et al.
Antioxidants (Basel, Switzerland)|February 25, 2022
Nuclear SOD1 in Growth Control, Oxidative Stress Response, Amyotrophic Lateral Sclerosis, and CancerJoyce Xu, Xiaoyang Su, Stephen K Burley, et al.
Pageof 7